Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2014
03/25/2014US8680048 Methods for treating HCV
03/25/2014US8680047 Fas peptide mimetics and uses thereof
03/25/2014US8680046 Inhibitors of viral integrase and methods of use
03/25/2014US8680045 Compositions of a peptide targeting system for treating cancer
03/25/2014US8680044 Methods and uses for inhibiting platelet coagulation
03/25/2014US8680043 Synthetic immunogenic glycoconjugate for melanoma immunotherapy
03/25/2014US8679830 Viral vectors
03/25/2014US8679810 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
03/25/2014US8679785 Knobs and holes heteromeric polypeptides
03/25/2014US8679780 Method of reducing immunological tolerance to malignancy
03/25/2014US8679540 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
03/25/2014US8679531 Vesicle compositions
03/25/2014US8679528 Hemostatic dressing
03/25/2014US8679526 Antimicrobial peroxidase compositions
03/25/2014US8679521 Treatment of ophthalmic conditions
03/25/2014US8679510 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
03/25/2014US8679506 Glucan-based vaccines
03/25/2014US8679503 Methods, compositions and kits relating to chitnases and chitnase-like molecules and inflammation disease
03/25/2014US8679487 Anti-interleukin-4 receptor antibodies
03/25/2014US8679486 High-potency botulinum toxin formulations
03/25/2014US8679482 Method of promoting healing of a tympanic membrane perforation using plasminogen
03/25/2014US8679481 Methods of reducing extravasation of inflammatory cells
03/25/2014US8679480 Method to inhibit neuropathic pain by intrathecal injection of protein phosphatases
03/25/2014US8679479 Methods for purifying pegylated arginase
03/25/2014US8679478 Methods of lysosomal storage disease therapy
03/25/2014US8679477 Use of SDF-1 to mitigate scar formation
03/25/2014US8679475 Methods and compositions for tissue regeneration
03/25/2014US8679472 Crystal of human interferon alpha 2B in complex with zinc
03/25/2014US8679471 Modulation of regulatory T cells by human IL-18
03/25/2014US8679470 Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
03/25/2014CA2753899C Polyalkylene glycol with moiety for conjugating biologically active compounds
03/25/2014CA2612282C Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha
03/25/2014CA2587284C Tripeptide and tetrapeptide thioethers
03/25/2014CA2524610C Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
03/25/2014CA2484538C Vectors with modified protease-dependent tropism
03/25/2014CA2474011C Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
03/25/2014CA2434672C Sfrp and peptide motifs that interact with sfrp and methods of their use
03/25/2014CA2404448C Genes involved in intestinal inflammatory diseases and use thereof
03/25/2014CA2368369C Docetaxel in combination with rhumab her2 for the treatment of cancers
03/25/2014CA2334696C Purification process for production of mannan-binding lectin and an mbl medicinal product
03/25/2014CA2306492C Human checkpoint kinase, hcds1, compositions and methods
03/20/2014WO2014043696A2 Compositions and methods for treating amyotrophic lateral sclerosis
03/20/2014WO2014043693A1 Oral formulations of angiotensin
03/20/2014WO2014043568A1 Stimulation of ovarian follicle development and oocyte maturation
03/20/2014WO2014043535A1 Compositions for the treatment of cancer
03/20/2014WO2014043397A1 Material and methods for diagnosing and treating kawasaki disease and kls
03/20/2014WO2014043334A1 Modulation of podoplanin mediated platelet activation
03/20/2014WO2014043265A1 Novel uses of neuraminidase inhibitors in infectious diseases
03/20/2014WO2014043103A1 Correctly folded etanercept in high purity and excellent yield
03/20/2014WO2014042463A1 Synthetically designed extracellular microenvironment
03/20/2014WO2014042401A1 Composition comprising cyclophilin a for preventing alopecia or improving hair restoration
03/20/2014WO2014042292A1 Composition comprising protein kinase c activator for promoting stem cell adhesion, and method for promoting stem cell adhesion
03/20/2014WO2014042290A1 Novel use method for cyclic depsipeptide
03/20/2014WO2014041537A1 Protein kinase c (pkc) alpha inhibitors for treatment and prevention of toxicities caused by radiation
03/20/2014WO2014041526A1 Peptide antagonists of the vasopressin-2 receptor
03/20/2014WO2014041508A1 Antimicrobial coating compositions
03/20/2014WO2014041425A1 Daptomycin formulations and uses thereof
03/20/2014WO2014041372A1 Lipases, polynucleotides encoding them and their uses
03/20/2014WO2014041195A1 Glucagon analogues
03/20/2014WO2014041119A1 Oncolytic viruses expressing immuno-nucleases
03/20/2014WO2014041111A1 Usp30 inhibitors and methods of use
03/20/2014WO2014040987A1 The use of a nucleic acid sequence encoding a type i interferon (ifn) originating from atlantic salmon as an antiviral and immune stimulating agent
03/20/2014WO2014040605A1 New peptides as a monotherapy in malignancy control
03/20/2014WO2014040302A1 Use of pedf-derived polypeptides for treating alopecia and/or hair depigmentation
03/20/2014WO2014040178A1 Trpv3 agonists for the treatment of skin conditions
03/20/2014WO2014040158A1 (argo)n-angiotensin-(1-7) peptide and pharmaceutical compositions for treating diseases
03/20/2014WO2014018763A3 Method of treating type i diabetes using apolipoprotein aiv
03/20/2014WO2014017845A3 A liquid formulation of long acting insulinotropic peptide conjugate
03/20/2014WO2014014389A3 Composition in gel form for the prophylaxis and treatment of periodontal diseases
03/20/2014WO2014006063A3 Complement split product c4d for the treatment of inflammatory conditions
03/20/2014WO2013188638A3 Endoribonucleases and methods of use thereof
03/20/2014WO2013023319A8 In vitro method for modification of the depletion profile of regulatory t cells present in a total population of splenocytes in a sample, culture and exposure of said cells to a medium with atp and polymyxin b
03/20/2014WO2012036962A3 C-terminal amidation of polypeptides
03/20/2014WO2012006640A3 Compositions and methods useful in enhancement of memory
03/20/2014WO2011066082A3 Markers associated with ribavirin-induced anemia
03/20/2014WO2011025635A3 Cosmetic uses of modified stressed yeast extracts and related compositions
03/20/2014WO2010151840A3 Albumin-free botulinum toxin formulations
03/20/2014WO2010120931A3 E2f as a target for treatment of hormone refractory prostate cancer
03/20/2014WO2010120374A3 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
03/20/2014WO2008019491A8 Inhibition of angiogenesis, tumorigenesis and cathepsin activity using insulin-like growth factor binding protein
03/20/2014US20140080764 Drug Containing Recombinant Mistletoe Lectins for Treating Malignant Melanoma
03/20/2014US20140080763 N-carboxyalkylauristatins and use thereof
03/20/2014US20140080762 Hyd1 peptides for relapsed cancer
03/20/2014US20140080759 Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
03/20/2014US20140080758 Treatment of kidney disorders with vip fragments
03/20/2014US20140080757 Glucagon analogues
03/20/2014US20140079777 Dry powder vancomycin compositions and associated methods
03/20/2014US20140079772 Compositions and methods for the treatment of cancer
03/20/2014US20140079754 Microfabricated nanopore device for sustained release of therapeutic agent
03/20/2014US20140079753 Bmp binding peptides
03/20/2014US20140079737 Use of immunomodulatory protein in promotion of wound healing or treatment of tissue injury
03/20/2014US20140079729 Method for improving endothelial function and decreasing cardiovascular morbidity using shilajit
03/20/2014US20140079727 New endolysin plyp40
03/20/2014US20140079713 Modulation of the sonic hedgehog pathway and uses thereof
03/20/2014US20140079712 Therapeutic Applications Targeting SARM1
03/20/2014US20140079692 Dosages for treatment with anti-egfr antibodies
03/20/2014US20140079688 Methods for treating ophthalmic disorders, diseases and injuries
03/20/2014US20140079687 Suture line Administration Technique using Botulinum Toxins
03/20/2014US20140079686 Methods For Treating Baldness And Promoting Hair Growth
03/20/2014US20140079680 Melatonin-based treatment and diagnosis of bile duct disease
1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 3163